OrthoPediatrics (KIDS) Misses Q4 EPS by 12c; Offers Guidance

OrthoPediatrics (NASDAQ: KIDS) reported Q4 EPS of ($0.35), $0.12 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $30.99 million versus the consensus estimate of $32.86 million.

GUIDANCE:

OrthoPediatrics sees FY2023 revenue of $146-149 million, versus the consensus of $148.79 million.

For earnings history and earnings-related data on OrthoPediatrics (KIDS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c